The question of anticoagulation in pulmonary arterial hypertension (PAH) has become increasingly complex. There is inconsistency in the registry data, and a lack of well performed randomized clinical trials to address this. So, we want to pose the question to you – what is your practice for anticoagulation in patients with idiopathic PAH?

Clinical Topics: Diabetes and Cardiometabolic Disease, Heart Failure and Cardiomyopathies, Prevention, Pulmonary Hypertension and Venous Thromboembolism, Vascular Medicine, Pulmonary Hypertension, Hypertension

Keywords: Hypertension, Pulmonary

< Back to Listings